Company ProfilePremium

Jisheng Group Holdings Limited

Company Profile Analysis

Ticker: 8133.HK吉盛集團控股有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Jisheng Group Holdings Limited - Company showcase

Year Founded & Workforce

2003

95 Employees

Jisheng Group Holdings Limited logo

Jisheng Group Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Jisheng Group Holdings Limited Overview

Jisheng Group Holdings is a micro-cap, GEM-listed industrial holding company. Its only operating business is a contract metal-casting operation based in Huizhou, Guangdong. It designs, develops, manufactures and sells cast components for pumps, valves, filters and food machinery, made from stainless steel, carbon steel, bronze and grey iron. Customers are mainly German manufacturers of flow-control devices and industrial machinery, with smaller customers in mainland China and the United States. Annual revenue is about HK$45–55 million, the group employs about 95 people, and it has reported a loss in every year reviewed. Since 2019 it has tried and abandoned several diversifications: financial printing (2020–2023), cultural-media joint ventures (2023–2024), and now a proposed move into cassava-starch supply-chain trading. The balance sheet is thin, with total equity of HK$14.5m at June 2026. The auditor has flagged a going-concern uncertainty, and the company depends on its chairman's financial support and on new borrowings. The investment case is a restructuring and optionality story, not a fundamentals story.


Company's own description (paraphrased from FY2025 annual results and 2026 Interim Report)

The company says it is an investment holding company. Through its subsidiaries it designs, develops, manufactures and sells cast metal products. Some products are made in its own facilities, located mainly in the PRC, and some are sourced from outside suppliers. It groups its products into four categories: (a) pump components, (b) valve components, (c) filter components and (d) food machinery components. The materials are stainless steel, carbon steel, bronze and/or grey iron. It names Germany as its largest market, with further customers in mainland China and the United States. Its principal customers are suppliers of flow-control devices, electromechanical equipment and industrial machinery and equipment. Management describes product quality and tailor-made production as the basis of its long-term customer relationships.

Independent characterisation

Jisheng is a small build-to-print contract foundry and component trader at the lower tier of the industrial-equipment value chain.

Revenue model: About 100% product sales. Revenue is recognised at a point in time under HKFRS 15 as "sales of cast metal products". There is no service, subscription or licensing revenue.

Value-chain position: Tier-2/Tier-3 component supplier. The group buys metal inputs from distributors of established metal manufacturers, most of which have distribution points in Guangdong near the Huizhou plant. It casts and machines or finishes parts to customer specification and exports them, mainly to Germany. A surcharge mechanism lets it pass through part of any raw-material and EUR/RMB or EUR/USD currency moves.

Hybrid make/buy: The filings say products are either sourced externally or made in-house. This means part of revenue is trading margin rather than value added in its own factory, which helps explain its low fixed-asset base (plant and equipment of only HK$1.4m at FY2025).

Customer types: Original equipment manufacturers (OEMs) and system suppliers in flow control (pumps, valves, filtration), food processing machinery and general industrial equipment.

Concentration: Three customers made up HK$15.0m, or 52.8%, of H1 2026 revenue (HK$7.6m, HK$5.2m and HK$2.2m). In H1 2025 the same three made up HK$26.9m, or 50.4%. Source: 2026 Interim Report, note 4.

End-markets: European (chiefly German) industrial capital goods, water and wastewater, process industries and food processing. Demand is cyclical and tied to European industrial capex.

Emerging business (announced, not yet operating): The company plans to become an integrated supply-chain participant in cassava starch across the PRC and Southeast Asia, covering procurement, inventory and pricing. Management talks about moving from facilitator to principal. No starch revenue had been reported as of 30 June 2026.

Strategy

Stated strategy themes (paraphrased from the FY2025 annual results "Future Prospects")

Expansion into cassava starch: Management says it is pursuing a strategic expansion into the cassava starch sector.

End-to-end supply-chain partner: The company wants to control procurement, inventory management and pricing in an integrated operating model.

Geographic target: The PRC and Southeast Asia. A PUBT summary of the annual report also mentions the Greater Bay Area and biodegradable-materials applications.

Leveraging regional networks: The company plans to use long-standing relationships with local industry leaders.

From facilitator to principal: The company wants to evolve its role in the market.

Prudence and agility: Management pairs the growth ambition with stated caution and capital preservation.

Core business: In metal casting, the stated themes are product quality, tailor-made production, operational efficiency and cost control over general and operating expenses.

The PUBT summary of the 2025 annual report says the board sees 2026 as a possible breakout year for starch.

Strategic initiatives in the last 24 months

InitiativeDateStatusComment
Capital Reorganisation (par reduced from HK$0.80 to HK$0.01; unissued shares subdivided 1:80)Proposed 26 Aug 2025; approved 30 Jul 2026; effective 2 Oct 2026CompletedRemoves the par-value floor on new share issues and offsets about HK$30.2m of accumulated losses
1-for-3 non-underwritten rights issue at HK$0.30 (about 114.55m rights shares; up to HK$34.4m gross, about HK$33m net), later repriced to HK$0.2626 Aug 2025 to 31 Mar 2026Terminated 26 May 2026; lapsedThe intended equity fix for going concern did not happen
Change of name to "Dincham Group…" (Chinese name per HKEX Chinese announcement)Proposed 26 Aug 2025Abandoned 31 Mar 2026—
Change in board lot sizeProposed 26 Aug 2025Linked to the reorganisation; final status not confirmed—
Cassava starch supply-chain entryAnnounced 31 Mar 2026Planning stage; no revenue or capex disclosedThe interim report states there are no plans for material investments
Constitutional update (hybrid meetings and e-voting)AGM 3 Jun 2026CompletedCompliance with GEM Core Shareholder Protection Standards
Cost controlOngoingAdministrative expenses rose 4.5% in FY2025 and 0.9% in 1H2026No quantified target

Guidance and medium-term targets

Not publicly disclosed. The company gives no numerical revenue, margin or profit guidance.

Products & Services

The company does not publish product-level specifications, prices or launch years. The catalogue below is the full extent of public disclosure.

There are no named flagship brands or platforms.

Product Portfolio

Product lineDescriptionMaterialsTarget customerLaunch / versionPricing model

Pump components

Cast housings, impellers and related parts for industrial pumps (exact parts not disclosed)

Stainless steel, carbon steel, bronze, grey iron

Pump OEMs and flow-control system suppliers (Germany-centred)

Long-standing core line; year not disclosed

Per-part contract pricing with raw-material and FX surcharge mechanism

Valve components

Cast valve bodies and parts (exact parts not disclosed)

Same

Valve and flow-control device manufacturers

—

Same

Filter components

Cast filter housings and parts

Same

Filtration equipment makers

—

Same

Food machinery components

Cast parts for food-processing equipment, typically stainless steel for hygiene

Same

Food machinery OEMs

—

Same

Externally sourced cast products

Products sourced from third-party foundries and resold

Various

Same customers

—

Trading margin

Cassava starch supply chain (planned)

Procurement, inventory management and pricing of cassava starch; positioned toward biodegradable-materials demand per a PUBT news summary of the 2025 annual report

—

Buyers in the PRC (incl. Greater Bay Area) and Southeast Asia

Announced Mar–Apr 2026; no revenue as of 1H2026

—

Financial printing (divested 2023)

Typesetting, translation, design, printing, binding, distribution and media placement for listed-company documents and IPO prospectuses

—

HK-listed issuers and IPO candidates

Acquired Jan 2020; disposed 2023

Job-based

“—” = not publicly disclosed.

Financial Narrative

Income statement: notes and sources

Sources: FY2023–FY2025 come from the HKEX annual results announcements (FY2024 announcement with FY2023 comparatives, and the FY2025 announcement). FY2021–FY2022 come from StockAnalysis (aggregator, continuing basis). FY2022 attributable loss comes from the Gelonghui summary of the FY2023 results. No interim dividends were paid.

Margins and growth (%)

Revenue CAGR FY2021–FY2025: −11.3% a year (HK$83.49m to HK$51.65m).

Half-year income statement

Gross margin was 13.1% in 1H2025 and 15.3% in 1H2026. Source: 2026 Interim Report.

Critical data-integrity flag: 1H2025 vs FY2025

The 2025 interim figures, restated as comparatives in the 2026 Interim Report, show 1H2025 revenue of HK$53.36m and cost of sales of HK$46.39m. The audited FY2025 figures are revenue of HK$51.65m and cost of sales of HK$36.36m. Subtracting one from the other gives an implied H2 2025 revenue of −HK$1.71m and cost of sales of −HK$10.03m, which is economically impossible. Google Finance's quarterly feed shows negative revenue for Q3 and Q4 2025, which is consistent with a reversal.

The FY2025 annual results do not explain this, and no restatement note was found. The likely explanations are:

  • unaudited interim revenue was later reversed or reclassified at audit, possibly because of principal-versus-agent treatment of externally sourced products; or

  • the interim figures were wrong.

There are further internal inconsistencies:

  • 1H2025 opening cash is shown as HK$2.31m, against a FY2024 closing balance of HK$6.23m.

  • 1H2025 attributable loss is shown as HK$0.80m in the statement, while the EPS note uses HK$0.326m.

  • The HK$0.474m NCI profit appears identically in both FY2024 and 1H2025.

Together these point to material weaknesses in financial reporting quality. Investors should treat the 1H2025 "115% growth" headline as unreliable.

Balance sheet

Sources: FY2025 annual results and the 2026 Interim Report. Gurufocus (aggregator, Jan 2026) showed debt/equity of 0.68 and cash-to-debt of 0.28, which is consistent with the FY2025 figures including leases.

Commentary. In 18 months, equity fell from HK$21.0m (FY2024) to HK$14.5m (June 2026), with losses eroding the base. Borrowings more than tripled in 1H2026 to HK$19.0m, of which HK$17.8m is current. The company attributes this to "other borrowing", and the lender is not identified. The rise in cash to HK$13.6m was funded entirely by debt.

Deposits paid to suppliers (HK$10.5m) are larger than trade receivables. These are a significant credit and recoverability exposure for a company of this size, and they may be linked to the planned starch procurement. The company reported no charged assets, no capital commitments and no contingent liabilities at either date.

The Capital Reorganisation that took effect on 2 Oct 2026 cancels HK$0.79 of paid-up capital per share, about HK$30.2m in total. This credit is set against accumulated losses. The step is technical: it does not change total equity, but it allows future equity to be issued below the old HK$0.80 par value.

Cash flow

FY2025 investing activity appears minimal: plant and equipment fell from HK$1.73m to HK$1.44m after depreciation of HK$0.84m, which implies capex of roughly HK$0.6m (analyst derivation, not disclosed). Dividends paid were zero in FY2023–FY2025. Buybacks were zero: no securities were purchased in FY2025 or 1H2026.

Use of 2023 rights-issue proceeds: Net proceeds were about HK$9.0m. The original plan was HK$2.25m for JV capital contributions, HK$2.25m for business opportunities and HK$4.5m for working capital. The JV allocation was redirected to working capital in December 2023, and all proceeds had been used by 31 December 2024 (2024 annual report extract, Jul 2025).

Ratios (analyst calculations from filings; year-end balances)

Notes: ROIC is not meaningful because NOPAT is negative. Net debt/EBITDA and interest coverage are not meaningful where EBITDA or EBIT is negative. The trailing-twelve-month ROE quoted by aggregators varies widely: Simply Wall St −6.99%, Wisesheets −5.04% at December 2025. Their methodologies differ and are not reconcilable with the filings. The filing-based figure (−22.4%) is preferred.

Trend commentary

  1. Structural revenue decline. Continuing revenue fell from HK$83.5m (FY2021) to HK$44.7m (FY2024), a 46% drop, as German industrial demand weakened and competition among Chinese foundries intensified. FY2025's recovery to HK$51.6m, described by management as a return to 2019 levels, was reversed in 1H2026 (−46.7% year on year). Management blamed weaker demand across industries and competitors diversifying their product offerings.

  2. Gross margin swings are driven by inventory provisions. Gross margin peaked at 35.3% in FY2024 with the help of an HK$2.45m reversal of inventory impairment. FY2025 included a HK$2.08m inventory impairment charge. Excluding these, the gross margin would have been about 29.8% in FY2024 and about 33.6% in FY2025 (analyst calculation, assuming both items sit in cost of sales). The year-on-year swing of HK$4.5m in provisions explains more than the whole HK$2.5m increase in FY2025 loss.

  3. Fixed-cost burden. Administrative expenses of roughly HK$15–16m a year, about 30% of revenue, are high for a business of this scale. Listed-company compliance costs (audit fees of HK$0.6m, legal and professional fees) are a meaningful drag. Staff costs were HK$16.0m in FY2025 against HK$17.0m in FY2024.

  4. Losses every year. The group has not reported a net profit in any year reviewed. Accumulated losses reached HK$84.1m by June 2026, against cumulative share capital plus premium of about HK$75.7m.

  5. Liquidity has deteriorated. Since FY2025 the group has relied on director advances and short-term "other borrowings". The auditor's going-concern paragraph and the lapse of the planned HK$33m rights issue leave funding unresolved.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityJurisdictionFunctional currencyRole

G. Force (Hong Kong) Limited

Hong Kong

USD

Trading and export of cast products (inferred from USD functional currency)

KTech Industrial Technology (Huizhou) Limited

PRC (Guangdong)

RMB

Manufacturing (Huizhou plant)

XETron Group Limited

Not stated (likely BVI)

—

Intermediate holding company created in the pre-IPO reorganisation

Jisheng Group (China) Limited

——

Acquired subsidiary named in the other-reserve note; activity not disclosed

河南吉盛文化傳媒集團有限公司 (Henan Jisheng Culture Media Group Co., Ltd.)

PRC (Henan)

—

Acquired subsidiary named in the other-reserve note; no segment revenue reported

“—” = not publicly disclosed.

Revenue by Segment and Segment Margins & Growth (%)

SegmentFY2021FY2022FY2023FY2024FY2025

Metal Casting revenue (HKD Mn)

83.4962.7153.7844.7351.65

Financial Printing revenue (HKD Mn, discontinued)

———00

Metal Casting YoY growth (%)

-2.5-24.9-14.2-16.815.5

Metal Casting share of continuing revenue (%)

100100100100100

Revenue by Segment

Metric (HKD K)1H20251H2026

Metal Casting segment revenue

53,36128,421

Metal Casting segment result

1,7984,169

Unallocated operating costs

-2,906-7,913

Finance costs

-77-270

Loss before tax

-326-4,014

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

83.4962.7153.7844.7351.65

Cost of sales (HKD Mn)

63.3048.1839.7528.9336.36

Gross profit (HKD Mn)

20.2014.5314.0215.8015.29

Selling and distribution expenses (HKD Mn)

——3.313.173.57

Administrative expenses (HKD Mn)

——17.9815.0615.73

Other income (HKD Mn)

——0.371.480.51

Finance costs (HKD Mn)

1.320.830.560.520.49

Operating income, StockAnalysis definition (HKD Mn)

-15.11-5.59-7.27-2.42-4.00

EBIT, analyst calc. = PBT + finance costs (HKD Mn)

——-6.90-0.95-3.49

D&A (HKD Mn)

———1.611.48

EBITDA, analyst calc. (HKD Mn)

———0.67-2.00

Pre-tax income, continuing (HKD Mn)

-16.15-6.23-7.46-1.47-3.98

Profit from discontinued operations (HKD Mn)

——6.0300

Net loss for the year, total (HKD Mn)

——-1.42-1.47-3.98

Net loss attributable to owners (HKD Mn)

—-12.14-5.04-1.94-3.98

Basic and diluted EPS (HK cents)

——-16.13-5.09-10.42

Dividends per share (HK cents)

——000

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

24.223.226.135.329.6

Operating margin, StockAnalysis basis (%)

-18.1-8.9-13.5-5.4-7.7

EBITDA margin (%)

———1.5-3.9

Net margin, attributable (%)

—-19.4-9.4-4.3-7.7

Revenue growth YoY (%)

-2.5-24.9-14.2-16.815.5

Financial Analysis

Metric1H20251H2026

Revenue

53,36128,421

Cost of sales

-46,390-24,076

Gross profit

6,9714,345

Other income

2,113990

Selling and distribution

-1,490-1,166

Administrative expenses

-7,843-7,913

Finance costs

-77-270

Loss before tax

-326-4,014

EPS basic, HK cents

-2.10-10.51

Financial Analysis (FY2024–Jun2026)

MetricFY2024FY2025Jun2026

Total assets

46,63446,27354,644

Plant and equipment

1,7291,4441,314

Right-of-use assets

984355299

Inventories

18,62616,23118,073

Trade and other receivables (current)

18,64219,15220,912

of which trade receivables, net

6,2035,9997,159

of which deposits paid to suppliers

9,82110,540—

Cash and cash equivalents

6,2298,64513,584

Bank and other borrowings, current

1,6835,40217,803

Bank and other borrowings, non-current

3,7102,7861,155

Total borrowings

5,3938,18818,958

Lease liabilities, total

6,3664,2253,369

Amount due to director (Ms. Woo)

6693,121843

Net debt, borrowings + leases − cash

5,5303,7688,743

Total liabilities

25,63128,54540,189

Total equity

21,00317,72814,455

Goodwill and intangibles

000

Net current assets (working capital)

25,59520,52114,807

Accumulated losses

-76,068-80,043-84,057

Financial Analysis — Net cash used in operating activities

Metric1H20251H2026

Net cash used in operating activities

-1,852-2,682

Net cash from (used in) investing activities

-986770

Net cash from financing activities

5,0776,206

Net change in cash

2,2394,294

Margin Analysis (%) and Financial Ratios (x)

RatioFY2024FY2025Jun2026

ROE, attributable loss / year-end equity (%)

-9.2-22.4—

ROA, loss / year-end assets (%)

-3.1-8.6—

Current ratio (x)

2.431.871.39

Debt/equity incl. leases (%)

56.070.0154.5

Company-reported gearing (%)

23.842.0131.15

Net debt / EBITDA (x)

8.3——

Interest coverage, EBIT / finance costs (x)

-1.8-7.1—

Asset turnover, revenue / year-end assets (x)

0.961.12—

Days inventory outstanding (days)

235163—

Days sales outstanding, trade receivables (days)

5142—

Days payables outstanding (days)

5939—

Cash conversion cycle (days)

227166—

Geographic Revenue

Region1H20251H2026

Germany

47,49120,697

PRC

4,5047,064

United States

1,366660

Others

00

Total

53,36128,421

Region share (%)

Region share (%)1H20251H2026

Germany

89.072.8

PRC

8.424.9

United States

2.62.3

Region YoY growth, 1H2026 vs 1H2025 (%)

Value

—

Germany

-56.4—

PRC

56.8—

United States

-51.7—

Share Price History

DatePriceSource

7 Jan 2026

0.40

Gurufocus

24 Apr 2026

0.36

etnet

18 May 2026

0.32

etnet

3 Jul 2026

0.29

Google Finance

30 Jul 2026

0.275 (−14.1% on the day)

StockAnalysis

52-week range (to Jul 2026)

0.26 – 0.48

Google Finance

Return metric

1Y

3Y

Valuation Multiples

MultipleJisheng

Market capitalisation

~HK$10.5m

Enterprise value (mcap + borrowings + leases − cash)

~HK$19.3m

P/E (TTM)

Not meaningful (TTM loss ~HK$7.7m*)

EV/EBITDA

Not meaningful (negative EBITDA)

EV/Sales, FY2025 revenue

~0.37x

P/B

~0.73x (Lixinger 0.59x on a different date and basis; Gurufocus 0.75x in Jan 2026)

Capital Markets

ItemDetail

Dividend policy and history

No dividends in FY2023, FY2024, FY2025 or 1H2026; Gurufocus states the company does not pay dividends

Equity issuance history

2023 rights issue (1-for-2, gross ~HK$10.2m); 2025–26 rights issue proposed then lapsed

Credit ratings (Moody's, S&P, Fitch)

Not rated

Debt maturity profile

HK$17.8m of borrowings current and HK$1.16m non-current (Jun 2026); leases HK$2.10m current and HK$1.27m non-current

Analyst consensus

No coverage

Liquidity

Very thin: average volume about 5,000–60,000 shares a day; board lot 8,000 shares before the reorganisation

Metric

FY2023

Dividends per share (HK cents)

0

Shares outstanding at year end (millions)

38.184

Analyst Conclusions

Management guidance and consensus

There is no quantitative guidance and no consensus. Management's qualitative outlook pairs caution on the global economy and the metal casting business with ambitions for cassava starch.

Bull case

  1. Recapitalisation now possible. With par at HK$0.01 from 2 Oct 2026, the company can raise equity at market prices. A raise of the size planned in 2025 (about HK$33m) would roughly triple equity and remove the going-concern overhang.

  2. The core business can be profitable at the gross level. The business earned HK$15–16m of gross profit at HK$45–52m revenue in FY2024–FY2025. A return to FY2025 volumes with tighter overhead could push it toward breakeven, since the FY2024 pre-tax loss was only HK$1.5m.

  3. Optionality. Domestic Chinese demand is growing (PRC revenue +57% in 1H2026). The starch pivot or an asset injection could rerate a company valued at only about 0.37x EV/Sales and 0.73x book.

Bear case

  1. Shrinking core and fragile finances. Revenue fell 47% in 1H2026 while borrowings tripled. With one rights issue already failed, a deeply discounted raise or further related-party dependence looks likely.

  2. Credibility gap. Audited FY2025 revenue is lower than reported 1H2025 revenue, and there are other unexplained inconsistencies. The interim numbers cannot be relied upon.

  3. Diversification record. Financial printing ended in a HK$17.6m impairment and the 2023 JVs were abandoned. The starch plan has no disclosed capex, contracts or team, and the interim report says there are no material investment plans.

Catalysts and monitorables (next 12 months)

CatalystExpected timingWhat to watch
New equity fundraising after the reorganisationQ4 2026 – 2027Size, price, underwriting, chairman participation
Q3 2026 quarterly results~Nov 2026Whether the revenue decline continues; borrowing levels
Refinancing of HK$17.8m current borrowingsWithin 12 monthsLender identity, terms, security
First starch-related contracts or revenue2026–2027Counterparties, margins, working-capital needs
FY2026 audit~Mar 2027Going-concern emphasis; any restatement of 2025 interim figures
Board changesOngoingAny CEO or CFO appointment; changes in INEDs
German industrial PMI and order trendsMonthlyLeading indicator for about 75–90% of revenue

Analyst verdict

Jisheng Group Holdings is best understood as a distressed GEM micro-cap built around a small, real but declining export foundry. It is not an operating growth story.

The foundry has merit. It has served German flow-control and food-machinery customers for years, earns gross margins near 30% when volumes hold, and needs little fixed capital. But it has never covered the roughly HK$19m of annual selling, administrative and listing overhead. Accumulated losses of HK$84m now exceed the HK$76m of share capital and premium ever raised.

The last 18 months have made things worse. The planned rights issue, the main remedy for an auditor-flagged going-concern uncertainty, was repriced and then abandoned in May 2026. The gap has been filled with short-term borrowings that now exceed total equity. At the same time, core revenue halved in the first half of 2026 as German demand collapsed.

The Capital Reorganisation that took effect on 2 October 2026 matters only as a precondition. It removes the HK$0.80 par floor so that equity can be issued near market price, but it brings in no capital. What happens next depends entirely on whether a credible raise follows, and on its terms.

The most serious analytical concern is reporting quality. Audited FY2025 revenue (HK$51.6m) is lower than the HK$53.4m the company reported for the first half of that year, and the filings offer no explanation. Combined with other internal inconsistencies, this means interim disclosures should be treated as provisional at best.

The cassava-starch pivot has no disclosed capital plan, partners or management depth, and it follows two abandoned diversifications. It should be treated as optionality, not value.

On about 0.7x book and 0.4x sales, the stock looks optically cheap. The book value, however, is shrinking by around HK$4m every six months, and dilution looks likely. Overall assessment: high-risk and speculative. The balance of evidence points to further dilution before any operating recovery. A rerating would most plausibly come from a well-supported recapitalisation or a corporate transaction, not from the metal casting business itself. Monitoring should focus on the terms of any fundraising, the refinancing of current debt, and the FY2026 audit opinion.


Primary sources: HKEX announcements and reports for stock code 8133. These include the name-change announcements of 15 Dec 2021, 24 Mar 2023 and 15 Aug 2023; the disposal announcement of 19 May 2023; the supplemental interim announcement of 31 Aug 2023; the change in use of proceeds of 18 Dec 2023; the JV termination of 5 Apr 2024; the FY2024 annual results of 31 Mar 2025; the corporate-action announcement of 26 Aug 2025; the FY2025 annual results of 31 Mar 2026; the 2026 Interim Report of 27 Aug 2026; the EGM poll results of 30 Jul 2026; and the reorganisation effective-date announcement of 30 Sep 2026. Secondary and aggregator sources: StockAnalysis (FY2021–FY2022 history, price), Simply Wall St, etnet, Google Finance, Gurufocus, Morningstar, Lixinger, Reuters/Tiger Brokers summaries, the PUBT/Webull summary, and Gelonghui/Zhitong/Moomoo news summaries.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure / notesCommitteesShareholding

Ms. Woo Lan Ying (胡蘭英)

Chairman and Executive Director

Chairman since at least Nov 2022; sole executive director from about May 2024 until 2025

Nomination (Chair), Remuneration

8,014,652 shares (20.99%)

Mr. Li Qizhi (李奇智)

Vice Chairman and Executive Director

——

1,909,200 shares (5.00%)

Ms. Leung Shuk Lan (梁淑蘭)

Independent Non-Executive Director

Since at least 2022

Remuneration (Chair), Audit, Nomination

—

Ms. Yuen Wai Man (袁慧敏)

Independent Non-Executive Director

Since at least 2022; has the accounting and financial management expertise required by GEM rules

Audit (Chair), Remuneration, Nomination

—

Mr. Au Sui Keung Albert (區瑞強)

Independent Non-Executive Director

Since at least 2022

Audit

—

“—” = not publicly disclosed.

Board & Management Changes

DateChangeSource

By 24 May 2024

Mr. Shang Ruisen (尚睿森) no longer an executive director; board reduced to one ED and three INEDs

HKEX list of directors, 24 May 2024

By 29 Aug 2025

Mr. Li Qizhi and Mr. Yang Yueyong (楊越勇) appointed executive directors

2025 interim announcement

10 Jul 2026

Change of directors announced. Mr. Yang Yueyong no longer listed from 30 Jul 2026 onward.

Lixinger list; HKEX poll results

1 Mar 2024

Company secretary changed; current company secretary is Chan Wing Ting

Moomoo/Zhitong; etnet

Governance Overview

Item (HKD K)1H20251H2026

Key management (directors) short-term benefits

688609

Major Shareholders

HolderShares% of issuedType

Ms. Woo Lan Ying

8,014,65220.99

Director, beneficial owner

Mr. Fang Jinhuo (方金火)

2,661,1506.97

Substantial shareholder

Mr. Cheung Siu Wo (張少和)

2,056,6005.39

Substantial shareholder

Mr. Li Qizhi

1,909,2005.00

Director, beneficial owner

Public / other

23,542,39861.65—

Competitive Landscape

Key Competitors

#CompanyListingRelevance to Jisheng
1

Riyue Heavy Industry (日月重工)

SSE: 603218

Large Chinese ductile-iron castings maker (wind and industrial)

2

Jiangsu Jixin Wind Energy (吉鑫科技)

SSE: 601218

Large castings producer

3

Guangdong Hongtu Technology (鴻圖科技)

SZSE: 002101

Guangdong-based die-casting group

4

Guangdong Wencan Die Casting (文燦股份)

SSE: 603348

Guangdong die-casting peer

5

Ningbo Tuopu Group (拓普集團)

SSE: 601689

Castings within auto components

6

Georg Fischer

SIX: GF

European casting and flow-control incumbent

7

Unlisted Guangdong and Zhejiang stainless-steel investment casters

—

Direct price competition for pump and valve components

8

Indian export foundries (Rajkot and Coimbatore clusters)

Various

Alternative low-cost source for European OEMs seeking to diversify away from China

9

Thai Wah PCL

SET: TWPC

Southeast Asian cassava starch major

10

Sanguan Wongse Industries

SET: SUN

Thai cassava starch producer

11

China Starch Holdings

HKEX: 3838

HK-listed starch producer (corn-based)

Competitor Detail

MetricJisheng (FY2025)

Revenue

HK$51.6m

Revenue growth

+15.4% (FY2025); −46.7% (1H2026)

Gross margin

29.6%

Net margin

−7.7%

Recent Developments

--

Company Snapshot

$6.6M

Revenue

95

Employees

$1.4M

Market Cap

2003

Founded

Kowloon, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Gross margin near 30%: 29.6% in FY2025 and 35.3% in FY2024, which is solid for contract casting and shows some pricing power with German customers.
  • Cost pass-through: A contractual surcharge mechanism covers raw-material and EUR/RMB/USD currency moves (FY2025 MD&A).
  • Asset-light base: Plant and equipment of only HK$1.44m (FY2025), giving low capital intensity and flexibility to make or buy.
  • Supportive controlling shareholder: The chairman's interest-free advances (HK$3.12m at FY2025) and a written undertaking not to demand repayment.
  • Clean charges: No charged assets, no contingent liabilities and no capital commitments (FY2025 and 1H2026).
  • Stable workforce: Headcount held at 95 from FY2024 to 1H2026, and management reports no difficulty recruiting.
  • Capital structure cleaned up: Par value cut to HK$0.01 from 2 Oct 2026, enabling future fundraising.

Weaknesses

  • Persistent losses: Losses every year reviewed, with accumulated losses of HK$84.1m (June 2026).
  • Going-concern uncertainty: The auditor's material-uncertainty paragraph in FY2025, with current liabilities of HK$23.5m against cash of HK$8.6m.
  • Customer concentration: Three customers made up 52.8% of 1H2026 revenue.
  • Geographic concentration: Germany made up 72.8% of 1H2026 revenue and 89.0% of 1H2025.
  • Reporting-quality red flags: The implied negative H2 2025 revenue, inconsistent opening cash and duplicated NCI figures.
  • Overhead burden: Administrative expenses of HK$15.7m, about 30% of revenue, in FY2025.
  • Slow-moving inventory: About 163–235 days of inventory, with provisions swinging by HK$4.5m between years.

Opportunities

  • Cassava starch: A move toward biodegradable-materials feedstock in Southeast Asia and the Greater Bay Area (FY2025 Future Prospects).
  • Domestic China growth: PRC revenue rose 57% year on year in 1H2026, to 24.9% of the mix.
  • Post-reorganisation equity raise: Now possible below the old HK$0.80 par, which could repair the balance sheet.
  • Recovery in European industrial capex: FY2025 revenue had already returned to 2019 levels once.
  • Food machinery components: Exposure to defensive food-processing capex.
  • Shell or optionality value: A GEM listing with a market capitalisation of about HK$10.5m could attract an asset injection. This is speculative, but such transactions are common among GEM micro-caps.

Threats

  • Funding risk: The planned rights issue lapsed (26 May 2026), and borrowings rose to HK$19.0m by June 2026, mostly current.
  • Demand collapse: 1H2026 revenue fell 46.7% year on year.
  • Raw-material inflation: Cited in FY2025 as almost cancelling out price increases.
  • FX: Unhedged EUR receipts produced a net exchange loss of HK$0.64m in FY2025.
  • Trade policy: US and EU tariffs and de-risking from Chinese suppliers. US revenue fell 52% in 1H2026, though the cause was not attributed by the company.
  • Regulatory scrutiny: GEM rules on sufficiency of operations could be applied if the core business keeps shrinking.
  • Execution risk in starch: No disclosed team, capex, contracts or experience, and the business is working-capital-heavy while the group is short of cash.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
31 Mar 2025FY2024 results: revenue HK$44.7m (−16.8%); gross profit +12.7%; attributable loss HK$1.94mLoss narrowed, helped by an inventory provision reversal
Apr 20252015 Share Option Scheme expires unusedNo equity incentive plan in place
25 Jul 20252024 annual report disclosures confirm 2023 rights proceeds fully usedShows the cash need behind a new raise
22 Aug 2025Board meeting notice for interim resultsRoutine
26 Aug 2025Capital Reorganisation, board-lot change, 1-for-3 rights issue at HK$0.30 and name change to "Dincham Group…" proposedPlanned recapitalisation worth up to about 3x market cap
29 Aug 20251H2025 results: revenue HK$53.36m (+115%), loss HK$0.3mLater contradicted by the FY2025 audited totals
19 Sep 2025Announcement on the corporate actions (likely a timetable update)Delay
22 Sep 2025Further announcement on the corporate actions—
24 Oct 2025Circular despatch delayedExecution slippage
Nov 2025—
28 Nov 2025Further circular delay—
18 Dec 2025Further circular delay—
27 Feb 2026Circular despatch pushed back again to 31 Mar 2026Repeated delays point to difficulty assembling disclosure
31 Mar 2026FY2025 results: revenue HK$51.6m (+15.4%), loss HK$4.0m, gross margin 29.6%; going-concern uncertaintyLoss widened; auditor emphasis
31 Mar 2026Supplemental placing agreement: rights price cut to HK$0.26; name change droppedWeaker terms
31 Mar 2026Cassava starch strategy disclosedPotential business pivot
31 Mar 2026Proposed Third Amended and Restated M&ACompliance
29 Apr 20262025 Annual Report publishedStrategy narrative on starch
8 May 2026Corporate-action announcement (likely a timetable revision)—
Q1 2026 (May)—
26 May 2026Placing agreement terminated; rights issue lapsesFunding plan fails
3 Jun 2026AGM: all resolutions passed, including the new M&AGovernance
30 Jun 2026Further delay of the Capital Reorganisation circular; revised timetable—
10 Jul 2026Circular and EGM notice for the stand-alone Capital Reorganisation; change of directors (Mr. Yang Yueyong departs)Board shrinks to five
30 Jul 2026EGM approves the Capital Reorganisation (2,174,452 votes for, 0 against); share price falls 14% that day to HK$0.275Low turnout (about 5.7% of issued shares voted)
14 Aug 2026Capital Reorganisation update—
27 Aug 20261H2026 results: revenue HK$28.4m (−46.7%), loss HK$4.0m, borrowings HK$19.0m, gearing 131%Sharp deterioration
30 Sep 2026Effective-date announcement for the Capital Reorganisation—
2 Oct 2026Capital Reorganisation effective; free share-certificate exchange runs until 2 Nov 2026Opens the way for future sub-HK$0.80 equity raises

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue fell from HKD 83.5 Mn in FY2021 to HKD 51.7 Mn in FY2025.
Jisheng Group Holdings Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue83.562.753.844.751.7
Cost of sales63.348.239.828.936.4
Gross profit20.214.51415.815.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.